Boehringer and Jazz collaborate on HER2+ breast cancer therapy
Boehringer Ingelheim and Jazz Pharmaceuticals collaborate on a Phase Ib study combining zontuximab and zanidatamab for HER2-positive breast cancer patients, aiming to improve outcomes for this aggressive cancer subtype.
SK Bioscience hires LG Chem veteran as production expert
SK Bioscience hires Cho Bong-joon, a production expert from LG Chem, as Vice President to enhance global manufacturing competitiveness and production process systems.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.